Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine

NCT02825576 is registered in ClinicalTrials.gov with Northern Sydney Anaesthesia Research Institute as lead sponsor.

NCT NCT02825576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02825576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine
Lead sponsor
Northern Sydney Anaesthesia Research Institute
Phase
Phase 4
Overall status
Terminated
Start date
December 3, 2018
Completion date
January 1, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary complications